Results for "Specialty Pharmaceutical Distribution Facts, Figures, and Trends"
Verification Network Update: Less than 60 Days Remain
Industry and service providers continue to work to implement the Drug Supply Chain Security Act’s (DSCSA) serialized saleable return milestone. With the end of FDA-granted enforcement discretion ending on November 27, 2020, and the industry simultaneously responding to COVID-19, it is all hands on deck to reach the compliance finish line.
Partnering in Response to COVID-19
The evolving COVID-19 “coronavirus” pandemic has upended the lives and routines of almost every American across the country. It is during these challenging times, however, that communities have shown their resolve by coming together to tackle problems and support one another.
How 2023 Will Shape the Future of Healthcare Supply Chain Resilience
Recently, HDA surveyed our distributor members and other subject matter experts to gain insights into current data and information sharing within the healthcare sector, and these findings have been distilled in our latest report, Healthcare Supply Chain Resilience and Data Illumination. This report documents the role of public-private partnerships in the COVID-19 response, while outlining some challenges and actionable recommendations to maintain long-standing data-sharing agreements. Read to learn more about these topics and the report's findings.
HDA Honors Heather Zenk of AmerisourceBergen With Distribution Management Award for Industry Leaders
The Healthcare Distribution Alliance (HDA) presented Heather Zenk, RPh, PharmD, President of Supply Chain Operations and Distribution Services, AmerisourceBergen, with the Distribution Management Award for Industry Leadership. The award, which recognizes an individual for their exceptional contributions to the pharmaceutical distribution industry, was presented today at the HDA 2022 Distribution Management Conference in Austin, Texas.